Società NewBridge Global Ventures, Inc.
Azioni
NBGV
US65080W1053
Prestatari di assistenza sanitaria
Attività
Numero di dipendenti: 7
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Lance Dalton
CEO | Chief Executive Officer | 60 | 01/08/20 |
Bob Johnson
PSD | President | - | - |
Chairman | - | 16/10/19 | |
Jesse Magallanes
COO | Chief Operating Officer | 40 | 01/01/19 |
Doug Mancosky
CTO | Chief Tech/Sci/R&D Officer | - | 17/10/19 |
Rick Hull
CTO | Chief Tech/Sci/R&D Officer | - | - |
Robert Szwajkos
BRD | Director/Board Member | 76 | 28/02/20 |
John Faris
SAM | Sales & Marketing | - | 01/01/21 |
Everett Farr
PRN | Corporate Officer/Principal | 67 | 28/08/20 |
Eric Anderson
PRN | Corporate Officer/Principal | - | 26/08/19 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Chairman | - | 16/10/19 | |
Robert Szwajkos
BRD | Director/Board Member | 76 | 28/02/20 |
Ellen Gee
PRN | Corporate Officer/Principal | 62 | 14/07/18 |
Lance Dalton
CEO | Chief Executive Officer | 60 | 01/08/20 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 64 098 055 | 21 476 809 ( 33,51 %) | 0 | 33,51 % |
Coordinate società
NewBridge Global Ventures, Inc.
1 Hawthorne Street Suite 24A
94105, San Francisco
+
http://newbridgegv.comSettore
Variaz. 1 gen. | Capi. | |
---|---|---|
+14,40% | 222 Mln | |
+2,06% | 211 Mln | |
+26,74% | 164 Mln | |
+300,00% | 121 Mln | |
-28,57% | 120 Mln | |
+26,09% | 114 Mln | |
+96,46% | 110 Mln | |
-53,09% | 98,07 Mln | |
-3,85% | 86,5 Mln |